In Brief: Biopharmaceutics
This article was originally published in The Tan Sheet
Executive Summary
Biopharmaceutics: Completes acquisition of Koromex, Vaginex and Feminique feminine product lines from London International Group subsidiary U.S. Holdings, Inc., the company announced March 18. Biopharmaceutics is planning line extensions for the brands, which currently generate annual sales of approximately $4 mil. ("The Tan Sheet" March 11, In Brief)...